[1]谭斯露 何胜虎.新型冠状病毒与SARS病毒的相似性及对心脏的影响[J].心血管病学进展,2020,(9):947-949.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.015]
　TAN Silu,HE Shenghu.Similarity of Novel Coronavirus and SARS Virus and Their Effects on Heart[J].Advances in Cardiovascular Diseases,2020,(9):947-949.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.015]
点击复制

新型冠状病毒与SARS病毒的相似性及对心脏的影响()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年9期
页码:
947-949
栏目:
出版日期:
2020-09-25

文章信息/Info

Title:
Similarity of Novel Coronavirus and SARS Virus and Their Effects on Heart
作者:
谭斯露1; 2 何胜虎 1
(1.江苏省苏北人民医院心内科,江苏 扬州 225001；2.中南大学,湖南 长沙 410083)
Author(s):
TAN Silu1; 2; HE Shenghu1
(1.Department of Cardiology,Northern Jiangsu Peoples Hospital,Yangzhou 225001Jiangsu,China；2.Central South University,Changsha 410083,Hunan,China)
关键词:
新型冠状病毒; 严重急性呼吸综合征; 心脏损伤; 心血管系统
Keywords:
Novel coronavirus ; Severe acute respiratory syndrome ; Heart injury ; Cardiovascular system
DOI:
10.16806/j.cnki.issn.1004-3934.2020.09.015
摘要:
2019新型冠状病毒（2019-nCoV）肺炎于2019年12月在湖北省武汉市爆发，随之在全国流行，世界许多国家均出现感染病例，这是距严重急性呼吸综合征和中东呼吸综合征等事件后冠状病毒对世界公共卫生风险的再一次警告。现有研究显示2019-nCoV与严重急性呼吸综合征冠状病毒（SARS-CoV）具有同源性。现就冠状病毒的一般特征、2019-nCoV与SARS-CoV二者的相似性以及对心脏的影响进行综述。
Abstract:
The outbreak of a novel coronavirus(2019-nCoV) pneumonia in Wuhan, Hubei Province,in December 2019, was followed by an epidemic throughout the country, and there were cases in many countries around the world, which is another warning of coronavirus to the world public health after SARS and MERS .Existing studies show that 2019-nCoV and SARS-CoV are homology. This article reviews the general characteristics of coronavirus, the similarities between 2019-nCoV and SARS-CoV,and their impacts on the heart.

参考文献/References:

[1] Huang C,Wang Y,Li X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J].Lancet,2020,395(10223):497-506. [2] Su S,Wong G,Shi W,et al.Epidemiology,genetic,recombination,and pathogenesis of coronaviruses[J].Trends Microbiol,2016,24(6):490-502. [3] Peiris JS,Yuen KY,Osterhaus AD,et al.The severe acute respiratory syndrome[J].N Engl J Med,2003,349(25):2431-2441.  [4] Chan-Yeung M,Xu RH.SARS:epidemiology[J].Respirology,2003,8 suppl:S9-S14. [5] Zaki AM,van Boheemen S,Bestebroer TM,et al.Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J].N Engl J Med,2012,367(19):1814-1820. [6] Lee J,Chowell G,Jung E.A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea:a retrospective analysis on control interventions and superspreading events[J].J Theor Biol,2016,408:118-126. [7]Lee JY,Kim YJ,Chung EH,et al.The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea,2015[J].BMC Infect Dis,2017,17(1):498. [8]Lu R,Zhao X,Li J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J]. Lancet,2020,395(10224):565-574. [9]Zhou P,Yang XL,Wang XG,et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin[J].Nature,2020,579(7798):270-273. [10]Wang M,Hu Z.Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting[J].Virol Sin,2013,28(6):315-317.  [11]Wrapp D,Wang N, Corbett KS, et al.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J].Science,2020,367(6483):1260-1263. [12]Holshue ML,DeBolt C,Lindquist S,et al.First case of 2019 novel coronavirus in the United States[J].N Engl J Med,2020,382(10):929-936. [13]Elfadil AA,Ahmed AG,Abdalla MO,et al.Epidemiological study of Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia, April-May 2015[J].Rev Sci Tech,2018,37(3):985-997. [14]Chen N,Zhou M,Dong X,et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,China:a descriptive study [J].Lancet,2020,395(10223):507-513.  [15]Badawi A,Ryoo SG.Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus(MERS-CoV):a systematic review and meta-analysis[J].Int J Infect Dis,2016,49:129-133.  [16]Jaillon S,Berthenet K,Garlanda C.Sexual dimorphism in innate immunity[J].Clin Rev Allergy Immunol,2019,56(3):308-321. [17]Binnie A,Tsang JLY,Dos Santos CC.Biomarkers in acute respiratory distress syndrome[J].Curr Opin Crit Care,2014,20(1):47-55. [18]Williams AE, Chambers RC.The mercurial nature of neutrophils:still an enigma in ARDS?[J].Am J Physiol Lung Cell Mol Physiol,2014,306(3):L217-L230. [19]Wong CK,Lam CWK,Wu AKL,et al.Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome[J].Clin Exp Immunol,2 004,136(1):95-103. [20]Liu K,Fang YY,Deng Y,et al.Clinical characteristics of novel corona virus cases in tertiary hospitals in Hubei Province[J].Chin Med J (Engl), 2020.DOI:10.1097/CM9.0000000000000744[Epub ahead of print]. [21]Guan WJ,Ni ZY,Hu Y,et al.Clinical characteristics of coronavirus disease 2019 in China[J].N Engl J Med,2020,382(18):1708-1720. [22]Wang D,Hu B,Hu C,et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-pneumonia in Wuhan,China[J].JAMA,2020,323(11):1061-1069. [23]Yang X,Yu Y,Xu J,et al.Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan,China:a single-centered,retrospective,observational study[J].Lancet Respir Med,2020,8(5):475-481. [24]Liu Y,Yang Y,Zhang C,et al.Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury[J].Sci China Life Sci,2020,63(3):364-374. [25]Xu Z,Shi L,Wang Y,et al.Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J].Lancet Respir Med,2020,8(4):420-422. [26]赵景民,周光德,孙艳玲,等.严重急性呼吸综合征的临床病理及发病机制研究[J].中华实验和临床病毒学杂志,2003,17(3):217. [27]赵景民,周光德,孙艳玲,等.1例地方非典型肺炎病例病理及病原学发现[J].解放军医学杂志,2003,28(5):379. [28]周光德,赵景民,王松山.SARS冠状病毒对心脏及其传导系统影响的病理学研究[J].解放军医学杂志,2014,29(1):52-54. [29]Yu CM,Wong RS,Wu EB,et al.Cardiovascular complications of severe acute respiratory syndrome[J].Postgrad Med J,2006,82(964):140-144.

相似文献/References:

[1]张艺文 蔡琳 秦莉 杨晓倩 汪汉.基于网络药理学的参麦注射液治疗新型冠状病毒感染合并心肌炎的机制研究[J].心血管病学进展,2020,(10):1101.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.024]
　ZHANG YiwenCAI LinQIN LiYANG XiaoqianWANG Han.Shenmai Injection for COVID-19 with Myocarditis Based on Network Pharmacology[J].Advances in Cardiovascular Diseases,2020,(9):1101.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.024]
[2]汪汉,刘汉雄,蔡琳.2019冠状病毒病的心血管表现[J].心血管病学进展,2020,(11):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
　WANG Han,LIU Hanxiong,CAI Lin.Cardiovascular Profiles in Corona V irus Disease 2019[J].Advances in Cardiovascular Diseases,2020,(9):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[3]杨晓倩 秦莉 张艺文 汪汉.苦参治疗新型冠状病毒感染合并心肌炎的网络药理学分析[J].心血管病学进展,2021,(6):566.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.021]
　YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Network Pharmacological Analysis of Sophora Flavescens on Novel Coronavirus Infection complicated with Myocarditis[J].Advances in Cardiovascular Diseases,2021,(9):566.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.021]

备注/Memo

备注/Memo:
通信作者：何胜虎，E-mail：yzhshys@163.com 收稿日期：2020-03-12
更新日期/Last Update: 2020-12-03